Search research articles
Contact Us
Filters
Showing results (711-720 of 726) with videos related to
Page
of 73
Sort By:
JAMA Pediatrics
|
April 8, 2024
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial
Oliver Schwartz, Katharina Vill, Michelle Pfaffenlehner, et al.
Journal of Neuromuscular Diseases
|
December 24, 2022
Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study
Astrid Pechmann, Max Behrens, Katharina Dörnbrack, et al.
Annals of Clinical and Translational Neurology
|
December 31, 2025
Whole-Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies
Laura Costa-Comellas, Mauro Monforte, Angel Sanchez-Montañez, et al.
Orphanet Journal of Rare Diseases
|
October 24, 2022
Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study
Astrid Pechmann, Max Behrens, Katharina Dörnbrack, et al.
Annals of Neurology
|
February 12, 2021
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale
Marni B Jacobs, Meredoith K James, Linda P Lowes, et al.
Frontiers in Neurology
|
April 1, 2022
Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach
Anna G Mayhew, Meredith K James, Ursula Moore, et al.
Molecular Microbiology
|
February 20, 2025
Future Directions of the Prokaryotic Chromosome Field
E A Abbondanzieri, A B Badrinarayanan, D Barillà, et al.
Journal of Neurology
|
February 27, 2024
5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2
Katharina Vill, Moritz Tacke, Anna König, et al.
Human Mutation
|
January 22, 2015
The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations
Catherine L Bladen, David Salgado, Soledad Monges, et al.
The Lancet Regional Health. Europe
|
February 16, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
René Günther, Claudia Diana Wurster, Svenja Brakemeier, et al.
Page
of 73
Search research articles
Search
Showing results (711-720 of 726) with videos related to
Sort By:
Page
of 73
JAMA Pediatrics
|
April 8, 2024
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial
Oliver Schwartz, Katharina Vill, Michelle Pfaffenlehner, et al.
Journal of Neuromuscular Diseases
|
December 24, 2022
Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study
Astrid Pechmann, Max Behrens, Katharina Dörnbrack, et al.
Annals of Clinical and Translational Neurology
|
December 31, 2025
Whole-Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies
Laura Costa-Comellas, Mauro Monforte, Angel Sanchez-Montañez, et al.
Orphanet Journal of Rare Diseases
|
October 24, 2022
Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study
Astrid Pechmann, Max Behrens, Katharina Dörnbrack, et al.
Annals of Neurology
|
February 12, 2021
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale
Marni B Jacobs, Meredoith K James, Linda P Lowes, et al.
Frontiers in Neurology
|
April 1, 2022
Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach
Anna G Mayhew, Meredith K James, Ursula Moore, et al.
Molecular Microbiology
|
February 20, 2025
Future Directions of the Prokaryotic Chromosome Field
E A Abbondanzieri, A B Badrinarayanan, D Barillà, et al.
Journal of Neurology
|
February 27, 2024
5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2
Katharina Vill, Moritz Tacke, Anna König, et al.
Human Mutation
|
January 22, 2015
The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations
Catherine L Bladen, David Salgado, Soledad Monges, et al.
The Lancet Regional Health. Europe
|
February 16, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
René Günther, Claudia Diana Wurster, Svenja Brakemeier, et al.
Page
of 73